Contractor Notice: SSP05 Fluoxetine 10mg tablets extended

Contractor Notice: SSP05 Fluoxetine 10mg tablets extended

June 2, 2020

On 12th March 2020 it was announced that the Secretary of State had authorised a Serious Shortage Protocol (SSP) to help manage the supply of Fluoxetine 10mg tablets. This SSP was put in place to manage stock and to try to ensure that fewer patients have to return to their prescriber.

SSP05 Fluoxetine 10mg tablets has been extended (previous end date was 12th June 2020) and will now end on 11th September 2020.

This expiry date may be brought forward or extended, and the content may be amended throughout this period. Pharmacists should ensure they are using the current version of an SSP before supplying an alternative product.

The SSP recommendations

The SSP provides that the capsule formulation of Fluoxetine may be supplied against prescriptions for Fluoxetine 10mg tablets as follows:

For prescriptions (NHS or private) requesting: Supply permitted under SSP05:
Fluoxetine 10mg tablets Fluoxetine 10mg capsules

The pharmacist must exercise their professional judgement to ensure the alternative product is suitable for the patient.

Current versions of SSPs can be found at:

Support in implementing the SSPs

The following resources have been developed to support pharmacy teams in using these protocols.

PSNC Briefing 015/20: Serious Shortage Protocols (SSPs): SSP05 – Fluoxetine 10mg tablets

Serious Shortage Protocols Operational Guidance

Serious Shortage Protocols Questions & Answers

PSNC’s Serious Shortage Protocols (SSPs) Endorsing Factsheet

PSNC Briefing 023/19: Serious Shortage Protocols – A guide for community pharmacy teams

Background information on SSPs

Further information on what SSPs are and when they may be used is available via the links below.

Serious Shortage Protocols (SSPs) on-demand webinar

Serious Shortage Protocols (SSPs) webpage

Posted in: , ,

More Latest News >